Need professional-grade analysis? Visit stockanalysis.com
$8.86B
14.51
28,000
7.43%
Price Chart
Risk-Adjusted Performance
Fleury S.A. (FLRY3) Price Performance
Fleury S.A. (FLRY3) trades on SA in BRL. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at BRL14.91, down 2.80% from the previous close.
Over the past year, FLRY3 has traded between a low of BRL10.61 and a high of BRL17.95. The stock has gained 37.2% over this period. It is currently 16.9% below its 52-week high.
Fleury S.A. has a market capitalization of $8.86B, with a price-to-earnings ratio of 14.51 and a dividend yield of 7.43%.
About Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- SA
- Currency
- BRL
- Country
- Brazil
Financial Metrics
- Revenue (TTM)
- $8.29B
- EBITDA
- $1.84B
- Profit Margin
- 7.39%
- EPS (TTM)
- 1.12
- Book Value
- 9.18
Technical Indicators
- 52 Week High
- R$18.10
- 52 Week Low
- N/A
- 50 Day MA
- R$16.46
- 200 Day MA
- R$15.04
- Beta
- 0.35
Valuation
- Trailing P/E
- 14.51
- Forward P/E
- 12.50
- Price/Sales
- 1.07
- Price/Book
- 1.64
- Enterprise Value
- $11.86B